Maria-luisa Maccecchini - Net Worth and Insider Trading

Maria-luisa Maccecchini Net Worth

The estimated net worth of Maria-luisa Maccecchini is at least $6 Million dollars as of 2024-05-11. Maria-luisa Maccecchini is the PRESIDENT AND CEO, 10% Owner of Annovis Bio Inc and owns about 976,775 shares of Annovis Bio Inc (ANVS) stock worth over $6 Million. Details can be seen in Maria-luisa Maccecchini's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Maria-luisa Maccecchini has not made any transactions after 2021-10-11 and currently still holds the listed stock(s).

Transaction Summary of Maria-luisa Maccecchini

Maria-luisa Maccecchini Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Maria-luisa Maccecchini owns 3 companies in total, including Annovis Bio Inc (ANVS) , Calmare Therapeutics Inc (CTTC) , and Lantern Pharma Inc (LTRN) .

Click here to see the complete history of Maria-luisa Maccecchini’s form 4 insider trades.

Insider Ownership Summary of Maria-luisa Maccecchini

Ticker	Comapny	Transaction Date	Type of Owner
ANVS	Annovis Bio Inc	2021-10-11	director & President and CEO
CTTC	Calmare Therapeutics Inc	2007-01-03	director
LTRN	Lantern Pharma Inc	2022-06-08	director

Maria-luisa Maccecchini Latest Holdings Summary

Maria-luisa Maccecchini currently owns a total of 1 stock. Maria-luisa Maccecchini owns 976,775 shares of Annovis Bio Inc (ANVS) as of October 11, 2021, with a value of $6 Million.

Latest Holdings of Maria-luisa Maccecchini

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ANVS	Annovis Bio Inc	2021-10-11	976,775	5.93	5,792,276

Holding Weightings of Maria-luisa Maccecchini

Maria-luisa Maccecchini Form 4 Trading Tracker

According to the SEC Form 4 filings, Maria-luisa Maccecchini has made a total of 2 transactions in Annovis Bio Inc (ANVS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Annovis Bio Inc is the acquisition of 18,000 shares on October 11, 2021, which cost Maria-luisa Maccecchini around $496,980.

Insider Trading History of Maria-luisa Maccecchini

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Maria-luisa Maccecchini Trading Performance

GuruFocus tracks the stock performance after each of Maria-luisa Maccecchini's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Maria-luisa Maccecchini is -38.91%. GuruFocus also compares Maria-luisa Maccecchini's trading performance to market benchmark return within the same time period. The performance of stocks bought by Maria-luisa Maccecchini within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Maria-luisa Maccecchini's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Maria-luisa Maccecchini

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	0.05
Relative Return to S&P 500(%)	-1.16

Maria-luisa Maccecchini Ownership Network

Ownership Network List of Maria-luisa Maccecchini

No Data

Ownership Network Relation of Maria-luisa Maccecchini

Maria-luisa Maccecchini Owned Company Details

What does Annovis Bio Inc do?

Who are the key executives at Annovis Bio Inc?

Maria-luisa Maccecchini is the director & President and CEO of Annovis Bio Inc. Other key executives at Annovis Bio Inc include Chief Financial Officer Henry Iii Hagopian , and Chief Financial Officer Jeffrey Brian Mcgroarty .

Annovis Bio Inc (ANVS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Annovis Bio Inc (ANVS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Annovis Bio Inc (ANVS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Annovis Bio Inc (ANVS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Annovis Bio Inc Insider Transactions

No Available Data

What does Calmare Therapeutics Inc do?

Who are the key executives at Calmare Therapeutics Inc?

Maria-luisa Maccecchini is the director of Calmare Therapeutics Inc. Other key executives at Calmare Therapeutics Inc include and director & President & CEO Mir Conrad F .

Calmare Therapeutics Inc (CTTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Calmare Therapeutics Inc (CTTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Calmare Therapeutics Inc (CTTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Calmare Therapeutics Inc (CTTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Calmare Therapeutics Inc Insider Transactions

No Available Data

What does Lantern Pharma Inc do?

Who are the key executives at Lantern Pharma Inc?

Maria-luisa Maccecchini is the director of Lantern Pharma Inc. Other key executives at Lantern Pharma Inc include 10 percent owner Leslie W. Kreis , 10 percent owner Bios Fund I, Lp , and 10 percent owner Fletcher Aaron G.l. .

Lantern Pharma Inc (LTRN) Insider Trades Summary

Over the past 18 months, Maria-luisa Maccecchini made no insider transaction in Lantern Pharma Inc (LTRN). Other recent insider transactions involving Lantern Pharma Inc (LTRN) include a net sale of 348,237 shares made by Leslie W. Kreis , and a net sale of 348,237 shares made by Bios Fund I, Lp .

In summary, during the past 3 months, insiders sold 288,000 shares of Lantern Pharma Inc (LTRN) in total and bought 0 shares, with a net sale of 288,000 shares. During the past 18 months, 696,474 shares of Lantern Pharma Inc (LTRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 696,474 shares.

Lantern Pharma Inc (LTRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Lantern Pharma Inc Insider Transactions

No Available Data

Maria-luisa Maccecchini Mailing Address

Above is the net worth, insider trading, and ownership report for Maria-luisa Maccecchini. You might contact Maria-luisa Maccecchini via mailing address: 1223 Foxglove Lane, West Chester Pa 19380.

Discussions on Maria-luisa Maccecchini

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.